Michael Alfieri

59 year

Health Technology

Consumer Services

Profile

Michael Alfieri worked as a Controller at Merrimack Pharmaceuticals from 2014 to 2017.
He then worked as a Controller & Executive Director-Finance at Anika Therapeutics from 2010 to 2014.
In 2017, he worked as a Vice President-Finance at Radius Health.
In 2018, he worked as VP-Finance, Chief Financial & Accounting Officer at Genocea Biosciences.
Mr. Alfieri received his undergraduate and graduate degrees from Bentley University.

Former positions of Michael Alfieri

Companies	Position	End
RADIUS HEALTH, INC.	Corporate Officer/Principal	2018-04-30
MERRIMACK PHARMACEUTICALS, INC.	Comptroller/Controller/Auditor	2016-12-31
ANIKA THERAPEUTICS, INC.	Comptroller/Controller/Auditor	2014-06-30
GENOCEA BIOSCIENCES, INC.	Director of Finance/CFO	2019-03-04

See the detail of Michael Alfieri's experience

Training of Michael Alfieri

Bentley University

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Alfieri's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
GENOCEA BIOSCIENCES, INC.	Health Technology
MERRIMACK PHARMACEUTICALS, INC.	Health Technology
ANIKA THERAPEUTICS, INC.	Health Technology

Private companies	1
Radius Health, Inc. Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.	Health Technology